APAC contract manufacturer built an AHK-Cu scalp-serum line for three brand owners in 12 weeks
An APAC cosmetic contract manufacturer was building a shared AHK-Cu scalp-serum platform for three indie hair-care brand-owner clients. Coordinated active sourcing, carrier-stability scoping, and per-brand documentation packets shipped in 12 weeks total.
Published April 30, 2026 · Anonymized customer story
Inquiry → first commercial lot
12 weeks
Brand-owner programmes served
3
Carriers validated
3 (low-ethanol, hydroglycerin, emulsion)
Destination-market notifications cleared
3 (all first-submission)
Challenge
The contract manufacturer was a mid-size APAC operation formulating on behalf of multiple indie brand owners. Three of its brand-owner clients had simultaneously briefed scalp-serum programmes built around AHK-Cu (Copper Tripeptide-3) and the Director of Formulation needed to source the active once, validate carrier stability once across the manufacturer's three reference scalp-serum bases (low-ethanol, hydroglycerin, and emulsion), and then ship per-brand documentation packets that each brand owner could use independently for destination-market notification. Three separate active-sourcing exercises would have eaten the timeline.
Approach
Pepoderma confirmed cosmetic-grade AHK-Cu availability against a single 12-month forecast covering all three brand-owner programmes, with the lot-level INCI documentation structured so per-brand packets could be generated from a single underlying lot release. The contract manufacturer's QC validated the first commercial lot against each of the three reference scalp-serum carriers; stability data on the three carriers was documented on the lot report as carrier-specific flags. Per-brand documentation packets (lot SDS, INCI verification, carrier-stability notes) shipped to each brand owner independently.
Outcome
Total elapsed time from initial inquiry to first commercial lot release: 12 weeks, with all three brand-owner programmes drawing on the same underlying lot. Each brand owner's destination-market notification (one EU CPNP, two APAC equivalents) cleared on first submission with the documentation supplied. The contract manufacturer has continued to draw on the same forecast for subsequent scalp-serum reorders without renegotiation.
“Three brand-owner programmes, three different destination markets, one underlying active source. The lot-level documentation structure was the part that mattered — being able to hand each brand owner their own packet without my team rewriting the same data three times.”